Information Provided By:
Fly News Breaks for July 31, 2019
Jul 31, 2019 | 09:19 EDT
SunTrust analyst Sandy Draper raised his price target on Medpace to $85 and kept his Buy rating after its Q2 earnings beat and raised FY19 outlook. The analyst cites the company's improved "request-for-proposal flow", high win rate, and lower cancellations leading to growth in revenues and bookings.
News For MEDP From the Last 2 Days
There are no results for your query MEDP